Drug Manufacturers - Specialty & Generic (industry)

Compare top 5 →
OverviewAI BriefPerformanceCompositionScoresCompaniesNews
Q-Score59
Market Cap$361.2B
Aggregate P/E79.99
Dividend Yield1.22%
1Y Return+42.6%
Advancing (1M)34.15%
AI summary

Returns

+42.6%over the year
Cap-weightedMedianUp
1M+7.3%-7.7%34%
3M+11.5%-7.9%41%
YTD+23.1%-10.3%40%
1Y+42.6%-20.5%37%

Led by the largest companies: the median company returned -20.5%.

Returns by horizon and breadth

This month's movers

Leaders
  • XERSXeris Biopharma Holdings, Inc.+51.0%
  • PCRXPacira BioSciences, Inc.+44.4%
  • BHCBausch Health Companies Inc.+40.7%
  • KNSAKiniksa Pharmaceuticals International, plc+25.1%
  • ETONEton Pharmaceuticals, Inc.+22.3%
Laggards
  • HIMSHims & Hers Health, Inc.-38.1%
  • LQDALiquidia Corporation-36.4%
  • SUPNSupernus, Inc.-33.6%
  • AMLXAmylyx Pharmaceuticals, Inc.-19.3%
  • AQSTAquestive Therapeutics, Inc.-16.5%
Every horizon's leaders and laggards

News sentiment

Open News

Largest companies

The map and every share

Size

Revenue$162.9B
Earnings$4.5B
Companies82
Concentration (HHI)0.14
Size and financials

Q-Score profile

59/ 100
Every score and metric

Valuation

Aggregate P/E79.99
Aggregate P/S2.22
Dividend yield1.22%
Earnings yield1.25%
Net margin2.77%
The valuation map

Revenue exposure

Outside the US45.98%
From Greater China—
Largest customer (avg.)—
Revenue covered69.09%
Size and financials